• groupe mutuel Logo
  • Helsana Logo
  • swica logo
  • medbase Logo
  • Hirslanden Logo
  • luks logo
  • groupe mutuel Logo
  • Helsana Logo
  • swica logo
  • medbase Logo
  • Hirslanden Logo
  • luks logo

Compassana is a joint project of Medbase, Hirslanden, Groupe Mutuel, Helsana, SWICA, LUKS Group and Trifork. Under the umbrella of Bluespace Ventures AG, as shareholders they ensure the establishment and systematic further development of Compassana.

Modern medical care is combined with the advantages of digitalisation. This creates the conditions for optimal communication between patients and healthcare providers.

Compassana connects medical and medical-related service providers and promotes their cooperation via a digital healthcare platform. It is the centrepiece of the smart ecosystem for health in Switzerland, invisible to patients. The platform optimises the integrated care of healthcare providers and the coordination of patient pathways. Patients use all the advantages on the app and medical service providers in the Compassana Med Cockpit

The Compassana app

Find relevant contacts, access documents, communicate securely with specialists, use the clear list of medications and the insurance guide. Further smart functions of the Compassana app are:

Mann mit Handy schaut auf App
  • Stethoskop

    Symptom check

  • Kalender

    Easy appointment booking

  • Medikamente

    Reorder medication

Das Compassana Med Cockpit

With the Compassana Med Cockpit, healthcare professionals can view patient data with their consent and use it together - simply smart.

 

Frau in Apotheke schaut auf Tablet
  • Perscription

    Complete master data

  • Liste

    Organised medication list

  • Schloss

    Secure communication

Strong together

Building our ecosystem requires combined forces and interdisciplinary collaboration. We are looking for like-minded people to join Compassana in order to take the Swiss healthcare system to the next, digital level. We welcome anyone who wants to join the Compassana ecosystem. Our specialist services for service providers, called Compassana Med, are open to all. Contact us now

 

 

Blog

E-prescription is scanned via QR code at the pharmacy.

06 May 2025

Swiss e-prescription initiative: Partners look ahead together

The Swiss e-prescription initiative, supported by the Swiss Pharmacists' Association pharmaSuisse, the Swiss Medical Association FMH and HIN, can look back on a successful year – and is focussing on the expansion and practical anchoring of e-prescriptions across the board in 2025.

Read more
Three features of the Compassana app are presented: insurance guide, claimed medication and symptom check

29 April 2025

Question of the month: What are the advantages of logging on to Compassana via your account with a partner insurer?

All patients over the age of 16 covered by the Swiss health system can enjoy the benefits of the Compassana app. Our partner insurers, Helsana, Groupe Mutuel and SWICA, offer their policyholders additional functionalities in the Compassana patient app.

Read more
A person wearing glasses and a blue hoodie speaks on stage. A large screen behind them displays the name "Arthur Germain" with the title "Co-Founder & CEO, ONEDOC.

22 April 2025

“We share an important principle”

Appointment booking specialist OneDoc and Compassana have been working together for many months already. Our common goal is to accelerate digitalisation for outpatient healthcare providers. Time for an interim summary from Arthur Germain, CEO of OneDoc.

Read more
Two glasses of lemonade with lemon slices, mint leaves and blue straws on a wooden board

15 April 2025

Sweet drinks are said to be responsible for ten per cent of diabetes cases

According to a recent study in the journal ‘Nature Medicine’, one in ten cases of diabetes worldwide can be attributed to the consumption of sugary drinks. In addition, one in 30 cases of cardiovascular disease is directly linked to sugary drinks. The international research team behind the study calls for policy action to reduce the health risks.

Read more
All blog articles